. Author manuscript; available in PMC: 2015 Oct 24.

Published in final edited form as: J Proteome Res. 2009 Mar;8(3):1293–1303. doi: 10.1021/pr800637z

Table 1.

Demographics and Clinicopathological Features of HCC Patients

Characteristics	Training Set (n = 55)	Validation Set (n = 25)	P value
Gender (M:F)	48:7	20:5	0.405
Age	53.4 ± 5.8 (Median: 54)	57.0 ± 2.2 (Median: 59)	0.228
Hepatitis (HBV / HCV / negative)	48 / 0 / 7	20 / 1 / 4	0.534
Tumor Size (cm)	8.79 ± 0.61 (Median: 8.00)	7.42 ± 1.06 (Median: 7.00)	0.277
Tumor Stage (AJCC TNM)
I–II	33	18	0.307
III–IV	22	7
Tumor Recurrence	22	8	0.331
Child’s Grade
A	53	25
B	2	0	0.340
C	0	0

Note: Both tumor and non-tumor specimens from 80 HCC patients were randomly assigned for the training and validation purposes. There was no apparent difference between the 2 sample sets.